Cigna Healthcare, Infirmary Health Reach Medicare Advantage Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
CIGNA (CI) PT Raised to $394 at Piper Sandler
November 4, 2024 4:04 PM ESTPiper Sandler analyst Jessica Tassan raised the price target on CIGNA (NYSE: CI) to $394.00 (from $392.00) while maintaining a Overweight rating.
The analyst comments "CI reported a pharmacy-led 3Q24 adjusted EPS beat and reiterated adjusted CY24 guidance. Notwithstanding the asset sale at Cigna Healthcare and... More



